Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2067896 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL28058050 | 0.84 | SMN1; SMN2 (0.48) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL11707997 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL11812000 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL9239091 | 0.80 | SMN1; SMN2 (0.47) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL9239093 | 0.80 | SMN1; SMN2 (0.47) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL11810271 | 0.80 | SMN1; SMN2 (0.52) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL11709538 | 0.80 | SMN1; SMN2 (0.52) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL7999137 | 0.79 | SMN1; SMN2 (0.51) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 | |
| SCHEMBL7999133 | 0.79 | SMN1; SMN2 (0.51) | SMN1; SMN2CHRNA1CHRNA3CHRNA7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977332-B2 | Insecticidal N-(heteroarylalkyl)alkanediamine derivatives | FMC CORPORATION (US) | 2011-07-12 | — | — | US | disclosed |
| US-20110065710-A1 | Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives | FMC CORPORATION | 2011-03-17 | — | — | US | disclosed |
| EP-1689231-A4 | INSECTICIDAL N-(HETEROARYLALKYL) ALKANEDIAMINE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2007-11-14 | — | — | EP | disclosed |
| EP-1689231-A2 | INSECTICIDAL N-(HETEROARYLALKYL) ALKANEDIAMINE DERIVATIVES | FMC CORPORATION (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005055715-A2 | INSECTICIDAL N-(HETEROARYLALKYL) ALKANEDIAMINE DERIVATIVES | FMC CORPORATION (US) | 2005-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065710-A1 | Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives | DDT, RABL6, ACHE | SMN1; SMN2 2602/4885CHRNA1 932/4885CHRNA3 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.